A subsidiary of Ott Scientific, Ethos Biosciences was formed to better serve diagnostic customers seeking accurate, repeatable and easy-to-use products. Building from our acquisition of Exocell™ Ethos Biosciences seeks to further advancements in kidney disease management through the development of RUO biomarker assays. Exocell™ ELISAs such as Albuwell™ have been developed by scientists for scientists, and are optimized for accuracy and workflow efficiency.
Additional Info
First-time Exhibitor:
Yes